Table 7.
References | Cancer | Treatment | Number of Patients; n | Method | Time Point for Measurements | Conclusion | Full Mouth Clinical Examination | Materials |
---|---|---|---|---|---|---|---|---|
Hou et al. [48]. | HNC | RT | 19 | 16S rRNA, V4 gene | 8 points: before RT, 10, 20, 30, 40, 50, 60, 70 Gy | 20 genera—significantly positively associated with their radiation dose; 10 genera—negatively associated | + | swabs |
Vesty et al. [50]. | HNC | RT/CRT | 19 | 16S rRNA, V3-V4 gene ITS1/ITS2 for fungi |
3 points: 0–20; 21–40; 41–60 Gy |
microbiota remain stable during RT; periopathogenic genera Porphyromonas and Tannerella, were all positively correlated with ≥ grade 2 OM | − | Saliva, swabs |
Zhu et al. [58]. | HNC | RT/CRT | 19 | 16S rRNA, V4 gene | 8 points: before RT, 10, 20, 30, 40, 50, 60, 70 Gy | 1. increase in the relative abundance of some Gram-negative bacteria; 2. severe mucositis harbored a significantly lower bacterial alpha diversity and higher abundance of Actinobacillus |
+ | swabs |
Reyes-Gibby et al. [59]. | HNC | RT/CH/CRT | 66 | 16S rRNA, V4 gene | 8 points | Changes in the abundance of genera over the course of treatment were associated with the onset of severe OM. |
− | swabs |
Hu et al. [60]. | HNC | RT | 8 | 16S rRNA, V1-V3 gene |
2 points: before and after RT | Temporal variation of major cores in relative abundance, negative correlation between the number of OTUs and radiation dose | + | Supragingival plaque |
Hu et al. [61]. | HNC | RT | 8 | 16S rRNA, V1-V3 gene |
7 points: once per week | Fluctuations in gen era synergistically involved in the development of RIOM | + | Supragingival plaque |
HNC—head and neck cancer; RT—radiotherapy; CT—chemotherapy; CRT—chemoradiotherapy, rRNA—ribosomal ribonucleic acid; OM—oral mucositis; OTU—Operational taxonomic unit; RIOM– radiation-induced oral mucositis.